DCCCX Mutual Fund

DCCCX Mutual Fund

NAV$26.96
See how much of DCCCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$44M
Expense Ratio
1.79%
Dividend Yield (Current)
-
Holdings
143
Inception Date
Aug 1, 2005
Fund Family
Nomura Asset Management Co Ltd
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
SEC 30-Day Yield
PRO

Performance

YTD+11.00%
1 Year+13.76%
3 Year+13.53%
5 Year+8.23%
10 Year+10.85%

Asset Allocation

Stocks: 99.15%
Cash: 0.85%
See how much of DCCCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TVTXTravere Therapeutics Inc1.99%
LGNDLigand Pharmaceuticals, Inc.1.83%
SUPNSupernus Pharmaceuticals Inc1.62%
IMX:SGImax Corp1.62%
FSSFederal Signal Corp1.50%
Top 10 Concentration: 15.49%Report Date: Aug 31, 2026
Download all 143 holdings for DCCCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$1.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

DCCCX Mutual Fund Overview

DCCCX Mutual Fund (Nomura Small Cap Core Fund Class C) is managed by Nomura Asset Management Co Ltd with $44.5M in net assets. DCCCX expense ratio is 1.79%, holding 143 positions across sectors including Health Care, Financials, Industrials. Inception date: 2005-08-01.

DCCCX performance shows a YTD return of 11.00%. The 1-year return is 13.76% and the 5-year return is 8.23%.

DCCCX top holdings include Travere Therapeutics Inc (2.0%), Ligand Pharmaceuticals, Inc. (1.8%), Supernus Pharmaceuticals Inc (1.6%), Imax Corp (1.6%), Federal Signal Corp (1.5%). Go to all DCCCX holdings, DCCCX sectors, or DCCCX dividends.

DCCCX can be compared against other funds. Use DCCCX overlap to find shared positions, or DCCCX vs another fund for a side-by-side view. DCCCX alternatives are available via the screener, along with tax-loss harvesting opportunities.